Adocia (LTS:0QAI) ROE % Adjusted to Book Value: -38.29% (As of Dec. 2025)


LTS:0QAI Adocia LTS:0QAI
33 GF Score
Price €4.19
GF Value €0.90
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Adocia ROE % Adjusted to Book Value?

Adocia LTS:0QAI +5.49% 33 ROE % Adjusted to Book Value is -38.29% as of Dec. 2025. GuruFocus rates LTS:0QAI with a GF Score™ of 33/100 and a GF Value™ of €0.90 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Adocia's ROE % for the quarter that ended in Dec. 2025 was -3,320.37%. Adocia's PB Ratio for the quarter that ended in Dec. 2025 was 86.71. Adocia's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -38.29%.

Adocia ROE % Adjusted to Book Value Related Terms

Adocia ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Adocia's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adocia ROE % Adjusted to Book Value Chart

Adocia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Adocia Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -38.29

LTS:0QAI vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Adocia's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adocia ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adocia's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Adocia's ROE % Adjusted to Book Value falls into.


LTS:0QAI
33GF Score
Adocia LTS:0QAI
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adocia ROE % Adjusted to Book Value Calculation

Adocia's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 86.71
=0.00%

Adocia's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-3,320.37% / 86.71
=-38.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -38.29% mean?
Adocia (LTS:0QAI) has a ROE % Adjusted to Book Value of -38.29% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Adocia and its competitors.
Is Adocia's ROE % Adjusted to Book Value too high?
Adocia's current ROE % Adjusted to Book Value is -38.29%. Overall, Adocia has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adocia's ROE % Adjusted to Book Value compare to VRTX and REGN?
Adocia's ROE % Adjusted to Book Value of -38.29% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Adocia and its competitors. Adocia's current ROE % Adjusted to Book Value is -38.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adocia stock overvalued right now?
Based on GuruFocus' analysis, Adocia (LTS:0QAI) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.90, compared to a current price of €4.19 — trading 365.8% above its estimated fair value. The current ROE % Adjusted to Book Value is -38.29%. Adocia's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Adocia (LTS:0QAI), the current ROE % Adjusted to Book Value is -38.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adocia (LTS:0QAI) Overvalued in 2026?

Based on GuruFocus' analysis, Adocia stock appears to be overvalued. The current stock price of €4.19 is trading 365.8% above its estimated GF Value™ of €0.90. GuruFocus considers Adocia to be Significantly Overvalued.

Key valuation signals for LTS:0QAI:

  • ROE % Adjusted to Book Value: -38.29%
  • GF Value™: €0.90 vs. price of €4.19 (365.8% above fair value)
  • GF Score™: 33/100 with 7 warning signs

No single metric tells the full story. See the LTS:0QAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adocia Business Description

Other Exchanges ADOC:FranceA89:Germany
Address 115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
33GF Score

Get the complete analysis for LTS:0QAI

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.19
Price
€0.90
GF Value